Pharmacokinetic characteristics of the triple inactivated plasma-derived Kedrion FIX concentrate: data from the KB037 clinical trial

The pharmacokinetics data of phase I/II clinical trials (EudraCT Number: 2005-006186-14) of the new, triple inactivated plasma-derived Kedrion FIX concentrate was designed according to the recommendations of SSC-ISTH [1,2]: 11 post-infusion FIX/time points samples during the first 72 h. The PK data...

Descripción completa

Detalles Bibliográficos
Autores principales: Morfini, Massimo, Guarnieri, Chiara, Macchia, Roberta, Scarpellini, Manuela, Mathew, Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Medicine and Dentistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452555/
https://www.ncbi.nlm.nih.gov/pubmed/32904339
http://dx.doi.org/10.1016/j.dib.2020.106164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452555/
https://www.ncbi.nlm.nih.gov/pubmed/32904339
http://dx.doi.org/10.1016/j.dib.2020.106164

Ejemplares similares